Shorter blood thinner course after delivery may be safe for some women
NCT ID NCT07342127
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 86 women with Factor V Leiden or Factor II mutations who had no history of blood clots. Researchers compared how long doctors prescribed blood thinners after childbirth (less than 2 weeks vs. 6 weeks) to see if shorter treatment was still effective at preventing dangerous clots. The goal was to find the best balance between preventing clots and avoiding side effects from medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACTOR II HETEROZYGOUS MUTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service Gynécologie Obstétrique - Hôpital de la Croix Rousse
Lyon, 69004, France
-
Service d'hémostase clinique - Hôpital Louis Pradel
Bron, 69500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Partner's support lower diabetes risk after gestational diabetes?
- Can a class tame pregnancy stress at the genetic level?
- A nationwide test: do home visits build healthier families?
- Can a simple calcium tablet help prevent postpartum bleeding?
- Can AI read ultrasound sweeps to tell Baby's position?
- Could a smart ring unlock secrets of pregnancy health?